Nitroxolin Forte Mip Pharma Polska (Nitroxoline)

Nitroxoline, the active ingredient in Nitroxolin Forte, is a quinolone derivative presented as an oral tablet for oral use. It is employed to treat urinary tract infections, including cystitis and prostatitis, in adult patients and is indicated for both uncomplicated and recurrent infections.

GNH USA supplies Nitroxolin Forte as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows stringent quality standards, offers full regulatory documentation, and coordinates logistics to ensure reliable global delivery of this EU‑authorized antibiotic.

Nitroxolin Forte (nitroxoline) is used in the management of bacterial infections of the urinary system.

Urinary tract infection (UTI): reduces bacterial load and alleviates symptoms such as dysuria and frequency. Cystitis: provides targeted antimicrobial activity to resolve bladder inflammation. Prostatitis: helps eradicate pathogens contributing to prostate infection and improves clinical outcomes. Recurrent UTI: can be employed as a therapeutic option to prevent recurrence of infection. Acute bacterial prostatitis: assists in eradicating causative organisms and reducing inflammation.

Nitroxoline may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Vomiting: occasional episodes. - Diarrhea: loose stools. - Headache: transient. - Dizziness: light‑headed sensation. - Skin rash: mild erythema.

Serious or Rare Side Effects: - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Severe allergic reaction: anaphylaxis or angioedema. - Blood dyscrasias: neutropenia or agranulocytosis. - Renal impairment: acute kidney injury.

When prescribing nitroxoline, clinicians should consider several safety precautions to minimize risks.

Renal function: assess baseline kidney function and monitor during therapy. Hepatic function: evaluate liver enzymes before and during treatment. Allergy: avoid use in patients with known hypersensitivity to nitroxoline or related quinolones. Pregnancy and lactation: use only if potential benefit justifies potential risk to fetus or infant. Drug interactions: review concomitant medications that may affect absorption or increase toxicity. Store at ambient temperature: keep tablets in original container, protect from moisture and direct sunlight.

Nitroxoline can interact with other medicines, altering its effectiveness or increasing adverse effects.

Major Interactions (Avoid): - Metal ion supplements (iron, calcium, magnesium): chelation reduces nitroxoline absorption – avoid co‑administration. - Nephrotoxic drugs (e.g., aminoglycosides, amphotericin B): combined use may increase risk of renal injury.

Moderate Interactions (Monitor Closely): - Warfarin: nitroxoline may potentiate anticoagulant effect – monitor INR. - Other quinolone antibiotics: additive CNS toxicity risk – observe for seizures or confusion. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increased gastrointestinal irritation – consider gastroprotection. - Probenecid: may decrease renal clearance of nitroxoline – adjust dose if needed.